-
to test hundreds of different conditions in parallel and assess their impacts on human immune responses, such as antibody production. We routinely work with industry partners to exploit
-
benefit from the extensive growth of the MCW Cancer Center, which is investing $100 million in five parallel research initiatives that include metabolomics, immune-oncology, structural biology, precision
-
platform enables us to test hundreds of different conditions in parallel and assess their impacts on human immune responses, such as antibody production. We routinely work with industry partners to exploit
-
parallel research initiatives that include Immuno-Oncology, Metabolomics, Structural & Chemical Biology, Precision Oncology, and Community-driven Research using Restorative Justice. This endowed cancer